Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
2011

Endocarditis Case Report: Treatment Failure with Vancomycin

Sample size: 1 publication Evidence: low

Author Information

Author(s): Beatriz Perazzi, Natalia Bello, Marta Mollerach, Carlos Vay, María Beatriz Lasala, Angela Famiglietti

Primary Institution: University of Buenos Aires

Hypothesis

Can methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin lead to treatment failure?

Conclusion

The case highlights the existence of subpopulations of methicillin-susceptible Staphylococcus aureus that have reduced susceptibility to vancomycin, which can result in treatment failure.

Supporting Evidence

  • The patient initially treated with cephalothin and gentamicin developed a rash and interstitial nephritis.
  • Vancomycin treatment failed initially but was later combined with gentamicin and rifampin, leading to resolution of the infection.
  • The vancomycin MIC for the isolates was determined to be 1 μg/mL, indicating reduced susceptibility.

Takeaway

A man got sick from a type of bacteria that didn't get better with a common medicine called vancomycin because some of the bacteria were a bit stronger than usual.

Methodology

The case involved a 66-year-old man treated with various antibiotics, including vancomycin, and monitored through blood cultures and echocardiograms.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

66-year-old Hispanic man with a history of diabetes and other health issues.

Digital Object Identifier (DOI)

10.1186/1752-1947-5-292

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication